Recent legal claims have brought attention to the potential link between the use of Tepezza, a medication used to treat thyroid eye disease (TED), and permanent hearing loss. Patients who have experienced hearing-related side effects after receiving Tepezza infusions are pursuing legal action against the manufacturers. Tepezza lawsuits allege that the drug makers failed to adequately warn patients and healthcare providers about the risks of hearing damage and or recommend essential audiological exams during treatment.
In one recent Tepezza lawsuit filed last month in U.S. District Court for the Northern District of Illinois, a woman from Texas claims that Horizon Therapeutics knew or should have known about the risk of hearing damage from Tepezza, yet failed to provide proper instructions for patients and the medical community about what steps to take to detect and avoid such injury. If you or someone you love took Tepezza and has suffered hearing loss, tinnitus, or another hearing-related injury, contact Consumer Safety Watch today for help.
Tepezza, also known as teprotumumab-trbw, is an injectable medication developed by Horizon Therapeutics to treat thyroid eye disease (TED) or Graves’ eye disease. TED is an autoimmune condition that causes inflammation and swelling of the eye tissue, leading to symptoms such as blurred vision, double vision, pain, and bulging eyes. Tepezza works by blocking a specific protein that triggers the immune response responsible for TED symptoms.
While Tepezza has been effective in reducing the symptoms of thyroid eye disease for many patients, it has also been increasingly associated with hearing-related side effects. Studies conducted before FDA approval reported hearing problems in 10% of patients who received Tepezza. However, more recent research suggests that the rate of hearing-related side effects associated with Tepezza could be as high as 65%. Common hearing-related side effects reported by patients taking Tepezza include:
Audiological exams, including baseline hearing tests before starting Tepezza treatment and regular monitoring during treatment, are crucial for detecting any changes in hearing and identifying potential hearing damage among users. These exams can help healthcare providers make informed decisions about the continuation of Tepezza treatment and initiate early interventions if necessary. By monitoring hearing throughout the treatment process, healthcare providers can potentially prevent permanent hearing damage in Tepezza users.
Patients who have experienced hearing loss or damage after receiving Tepezza infusions are pursuing legal claims against the manufacturers, alleging that they failed to adequately warn about the risk of hearing-related side effects and did not recommend audiological exams during treatment. In this latest Tepezza lawsuit, the plaintiff claims that she could have avoided permanent damage to her hearing if her doctors had been warned about the importance of conducting hearing tests before and after receiving Tepezza infusions.
These Tepezza claims are supported by recent studies that have highlighted the potential link between the TED drug and hearing loss. One small study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting, reported that 65% of patients who received Tepezza experienced hearing-related problems, significantly higher than the initial 10% reported during the drug’s clinical trials. This study and others suggest that the manufacturer may have underestimated the risk of hearing damage associated with Tepezza.
Individuals who have suffered hearing loss or damage after receiving Tepezza infusions may be eligible to file product liability lawsuits seeking compensation for their injuries. These legal claims aim to hold the manufacturers accountable for their alleged failure to provide adequate warnings and recommendations for audiological exams before and during Tepezza treatment. By pursuing legal action against Horizon Therapeutics, affected individuals hope to recover financial compensation for medical expenses, lost wages, pain and suffering, and other damages caused by hearing loss or damage related to Tepezza treatment.
The potential link between Tepezza treatment and hearing loss has prompted a growing number of legal claims against the manufacturers. Research studies have revealed a higher prevalence of hearing problems among Tepezza users than initially reported during clinical trials, and patients who have experienced hearing-related side effects after receiving Tepezza infusions are pursuing compensation for their injuries. Audiological exams play a crucial role in monitoring hearing during treatment and detecting any changes or potential damage. If you have experienced hearing loss or damage after receiving Tepezza infusions, it is important to consult with a knowledgeable Tepezza attorney to understand your rights and explore your options for seeking compensation.